Carcinoembryogenic antigen (CEA) is a group of glycoproteins which are produced during the fetal developmental stages by gastrointestinal tissues. CEA is responsible for cell adhesion. Healthy adults do not have CEA concentrations. However, smoking and certain medical conditions such as colorectal cancer, breast cancer etc. can mark the presence of CEA in the body. Thus, CEA based diagnostic assays are used for the detection of such cancers and to check the treatment efficiency during the therapeutic period by a physician.

In 2017, studies of the NCBI suggested that the global burden of colorectal cancer will increase by 60%, leading to 2.2 million new cancer cases and 1.1 million deaths by 2030. This will increase the colorectal cancer diagnostic demands, thereby propelling the market growth.

The global carcinoembryonic antigen market is expected to grow 6.7% during the forecast period.

Carcinoembryonic Antigen Market Segmentation:

The global carcinoembryonic antigen market has been segmented on the basis of application, sampling, and end user.

Based on application, the market has been segmented into colorectal, pancreatic, breast, lung cancer, and others.

Based on sampling, the market has been segmented into antecubital, peritoneal, pleural, serebrospinal, and others.

Based on the end users, the market has been segmented into hospitals, diagnostic centers, research centers, and others.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/772

Carcinoembryonic Antigen Market Key Players

Some of key players profiled in the report are Lee BioSolutions, F. Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated., Correlogic Systems, Inc, Genway Biotech, Inc., Abbott., RayBiotech, Inc., Abcam plc., Biocare Medical, LLC, and Biocare Medical, LLC.

Carcinoembryonic Antigen Market Regional Analysis

The Americas account for the largest share in the carcinoembryogenic antigen market. The Americas mainly include countries like the U.S. and Canada. Increasing prevalence of cancer and high healthcare expenditures within the region will boost the market growth over the assessment period.

Europe is the second highest revenue generating region in the global carcinoembryogenic antigen market. Increasing prevalence of cancer, fast adoption of new technologies and presence of developed countries like Germany and U.K within the region will boost the market growth during the forecasted period.

The Middle East & Africa is expected to grow slower than the global average. The Middle Eastern countries, for instance, UAE and Saudi Arabia dominates the market due to high income and the government support to improve public health.

Table Of Content

1. Report Prologue

2. Introduction

2.1 Definition

2.2 Scope Of The Study

2.3 Research Objective

2.4 Assumptions

2.5 Limitations

2.6 Market Structure

2.7 Market Segmentation

3. Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Forecast Model

TOC Continued….!

Browse Complete Report Details @

https://www.marketresearchfuture.com/reports/carcinoembryonic-antigen-market-772

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: [email protected]